BHRT for Menopause

22.06.2015

A patient currently going through menopause had tried many different transdermal delivery options for BHRT to help manage her symptoms. The prescribing Doctor tested her blood levels and found that she was not absorbing the BHRT despite using very high concentrations.

ACPHARM addressed this by customising the base used to compound her BHRT to Fagron Fitalite base, with an added penetration agent. The results are yet to be quantified by a follow-up serum analysis, but already the patient has experienced a very significant improvement in her menopausal symptoms.